Latest filings (excl ownership)
8-K
Results of Operations and Financial Condition
4 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
8-K
Zomedica Provides Corporate NYSE American Listing Update
15 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
29 Feb 24
DEFA14A
Additional proxy soliciting materials
20 Feb 24
DEFA14A
Additional proxy soliciting materials
6 Feb 24
DEFA14A
Additional proxy soliciting materials
31 Jan 24
DEFA14A
Additional proxy soliciting materials
26 Jan 24
DEFA14A
Additional proxy soliciting materials
24 Jan 24
DEFA14A
Additional proxy soliciting materials
17 Jan 24
DEF 14A
Definitive proxy
17 Jan 24
PRE 14A
Preliminary proxy
5 Jan 24
8-K
Results of Operations and Financial Condition
13 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Entry into a Material Definitive Agreement
10 Oct 23
8-K
Zomedica Provides Corporate Update
13 Sep 23
8-K
Zomedica Closes Acquisition of Structured Monitoring Products adding revolutionary
6 Sep 23
8-K
Results of Operations and Financial Condition
10 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 23
8-K
Results of Operations and Financial Condition
11 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Entry into a Material Definitive Agreement
11 May 23
8-K
Other Events
9 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
8-K
Zomedica Appoints New Chief Financial Officer
17 Mar 23
8-K
Revenue up 361% from 2021 through combination of acquisitions and organic growth
15 Mar 23
10-K
2022 FY
Annual report
15 Mar 23
8-K
Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022
9 Feb 23
8-K
Entry into a Material Definitive Agreement
23 Jan 23
8-K
Zomedica expands relationship with Structured Medical Products and begins commercializing VetGuardian wireless monitors
19 Jan 23
8-K
Results of Operations and Financial Condition
14 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
24 Aug 22
8-K
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million
15 Aug 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
8-K
Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health
20 Jul 22
8-K
Zomedica Announces New Global Manufacturing & Distribution Center
8 Jul 22
Latest ownership filings
4/A
JOHNNY D POWERS
18 Dec 23
4
JOHNNY D POWERS
18 Dec 23
4
JOHNNY D POWERS
20 Nov 23
4
LARRY C HEATON II
17 Nov 23
4
JOHNNY D POWERS
16 Nov 23
4
Russell Kevin Klass
14 Nov 23
4
Russell Kevin Klass
9 Nov 23
3
Russell Kevin Klass
9 Nov 23
4
LARRY C HEATON II
26 May 23
4
JOHNNY D POWERS
25 May 23
4
Peter Donato
20 Mar 23
3
Peter Donato
20 Mar 23
4
JOHNNY D POWERS
13 Dec 22
4
Robert Cohen
13 Dec 22
4
Pamela Nichols
13 Dec 22
4
Sean Whelan
13 Dec 22
4
Jeffrey M Rowe
13 Dec 22
4
Rodney James Williams
13 Dec 22
4
CHRISTOPHER ROSS MACLEOD
13 Dec 22
4
LARRY C HEATON II
6 Oct 22
4
Pamela Nichols
2 Sep 22
3
Pamela Nichols
2 Sep 22
3
Karen DeHaan-Fullerton
22 Jun 22
3
Anthony K Blair
21 Jun 22
4
Adrian Lock
1 Mar 22
4
JOHNNY D POWERS
22 Nov 21
4
Adrian Lock
10 Nov 21
3
Adrian Lock
10 Nov 21
4
LARRY C HEATON II
5 Oct 21
3
LARRY C HEATON II
5 Oct 21
4
Sean Whelan
13 Sep 21
3
Sean Whelan
13 Sep 21
4
Robert Cohen
30 Jun 21
4
JOHNNY D POWERS
16 Jun 21
4
Robert Cohen
1 Jun 21
4
JOHNNY D POWERS
17 May 21
4
Christopher Wolfenberg
13 May 21
4
Rodney James Williams
13 May 21
4
Jeffrey M Rowe
13 May 21
4
JOHNNY D POWERS
13 May 21